While the last few years could reasonably be described as chaotic for our industry, we are looking at the coming months and years as the time for cannabis companies to establish more organized and structured practices and focus on the fundamentals of running their businesses. One good reason for greater focus: an increase in the …
by Michael Apstein The second half of 2019 saw a punishing devaluation of the publicly traded cannabis companies with drops of 60% or more after failures to meet performance expectations1. I hadn’t predicted it, but I had listened intently at the various canna-business conferences in 2018 and early 2019 as alternate predictions were made …
2020 Cannabis Investing: Why I Like Early Stage & Emerging Companies Read More »
by Scott L. Greiper The first half of 2020 saw a wild ride in investment and M&A activity within the cannabis and hemp industries. Gyrating stock prices of public companies and the COVID-10 pandemic caused a sharp decline in investment activity in the first quarter of 2020. However, the second quarter of 2020 saw a …
Investment and M&A Activity in Cannabis and Hemp Read More »
By Mitch Baruchowitz As Illinois becomes the 11th state to legalize cannabis for adult-use, and other states look to follow suit, it is important to look at what the normalized, total addressable market (TAM) is in cannabis since that is one of the driving factors of the global opportunity. At Merida, it is our belief …
